1.Hallucinations after Ingesting a High Dose of Benzydamine Hydrochloride.
Burak CAN ; Ihsan OZ ; Husameddin OZER ; Turgay SIMSEK
Clinical Psychopharmacology and Neuroscience 2016;14(4):407-408
No abstract available.
Benzydamine*
;
Hallucinations*
2.Features of hallucination in schizophrenia
Journal of Medical Research 2005;38(5):70-74
The hallucination are common and have an important role in diagnosing schizophrenia. Objectives: To describe and to follow up the evolution of the hallucination in schizopprenia. 40 patients with schizophrenia met to ICD.10 criteria and have hallucination were treated by anti-psychotic drugs in National Institute of Mental Health from September 1999 to November 2000. Methods: cross - sectional study. Results: The hallucination symptoms in the patients were: 92.5% had auditory hallucination, 12.5% had visual hallucination and 2.5% had olfactory hallucination. Most of auditory hallucination was comments located in head. 91.6% hallucinations were disappeared when the patients were treated by anti-psychotic drugs. Conclusions: Most of hallucinations are auditory, visual and olfactory. Hallucinations are likely sensitive to anti-psychotic drug.
Schizophrenia
;
Hallucinations
3.Psychopathological consideration on the hallucinations of schizophrenics by Hutt adaptation of Bender-Gestalt test and mini-mental test.
Chong Ho PARK ; Kuy Haeng LEE ; Sang Woo OH
Journal of Korean Neuropsychiatric Association 1992;31(2):258-266
No abstract available.
Bender-Gestalt Test*
;
Hallucinations*
4.Manic patients with delusions or hallucinations.
Hee Cheol KIM ; Young Nam PARK ; Jae Chang HA
Journal of Korean Neuropsychiatric Association 1992;31(1):93-105
No abstract available.
Delusions*
;
Hallucinations*
;
Humans
5.Features of hallucinations in schizophrenia
Journal of Practical Medicine 2005;505(3):77-79
The hallucinations are common and have an important role in diagnosing schizophrenia. Objectives: To describe and to follow-up the evolution of the hallucinations in schizopprenia. 40 schizophrenic in patients in accordance with ICD.10 criteria, who have hallucinations, are treated by anti - psychotics in National Institute of Mental Health from September 1999 to November 2000. Methods: using the method of cross - sectional study. Results: The hallucinations of the patients were: 92.5% had auditory hallucination, 12.5% had visual hallucination and 2.5% had olfactory hallucination. Most of auditory hallucinations are comment, located in head. 91.6% hallucinations are disappeared when the patients were treated by antipsychotics. Conclusions: Most of hallucinations are auditory hallucinations, visual hallucinations and olfactory hallucination. Hallucinations are likely sensitive to antipsychotics
Schizophrenia
;
Hallucinations
;
Diagnosis
6.Short-term outcome in manic patients with delusions or hallucinations.
Hee Cheol KIM ; Young Nam PARK ; Jae Chang HA
Journal of Korean Neuropsychiatric Association 1992;31(4):697-707
No abstract available.
Delusions*
;
Hallucinations*
;
Humans
7.Familial Creutzfeldt–Jakob Disease with a PRNP Mutation at Codon 180 Presented with Visual Hallucinations and Illusions
Dong Woo RYU ; Yun Jeong HONG ; Jeong Wook PARK ; Si Baek LEE ; Seong Hoon KIM ; Yongbang KIM ; Min Jae SEONG ; Byung Seok KIM
Dementia and Neurocognitive Disorders 2019;18(3):105-107
No abstract available.
Codon
;
Hallucinations
;
Illusions
8.High Dose Ofloxacin-induced Bimodal Hallucinations in a Four Years Old Child.
Manish PAWAR ; Shamsundar JADHAV
Clinical Psychopharmacology and Neuroscience 2018;16(2):232-233
No abstract available.
Child*
;
Hallucinations*
;
Humans
9.Are Auditory Hallucinations Related to the Brain's Resting State Activity? A 'Neurophenomenal Resting State Hypothesis'.
Clinical Psychopharmacology and Neuroscience 2014;12(3):189-195
While several hypotheses about the neural mechanisms underlying auditory verbal hallucinations (AVH) have been suggested, the exact role of the recently highlighted intrinsic resting state activity of the brain remains unclear. Based on recent findings, we therefore developed what we call the 'resting state hypotheses' of AVH. Our hypothesis suggest that AVH may be traced back to abnormally elevated resting state activity in auditory cortex itself, abnormal modulation of the auditory cortex by anterior cortical midline regions as part of the default-mode network, and neural confusion between auditory cortical resting state changes and stimulus-induced activity. We discuss evidence in favour of our 'resting state hypothesis' and show its correspondence with phenomenal, i.e., subjective-experiential features as explored in phenomenological accounts. Therefore I speak of a 'neurophenomenal resting state hypothesis' of auditory hallucinations in schizophrenia.
Auditory Cortex
;
Brain
;
Hallucinations*
;
Schizophrenia
10.Transcranial Direct Current Stimulation in Schizophrenia.
Sri Mahavir AGARWAL ; Venkataram SHIVAKUMAR ; Anushree BOSE ; Aditi SUBRAMANIAM ; Hema NAWANI ; Harleen CHHABRA ; Sunil V KALMADY ; Janardhanan C NARAYANASWAMY ; Ganesan VENKATASUBRAMANIAN
Clinical Psychopharmacology and Neuroscience 2013;11(3):118-125
Transcranial direct current stimulation (tDCS) is an upcoming treatment modality for patients with schizophrenia. A series of recent observations have demonstrated improvement in clinical status of schizophrenia patients with tDCS. This review summarizes the research work that has examined the effects of tDCS in schizophrenia patients with respect to symptom amelioration, cognitive enhancement and neuroplasticity evaluation. tDCS is emerging as a safe, rapid and effective treatment for various aspects of schizophrenia symptoms ranging from auditory hallucinations-for which the effect is most marked, to negative symptoms and cognitive symptoms as well. An interesting line of investigation involves using tDCS for altering and examining neuroplasticity in patients and healthy subjects and is likely to lead to new insights into the neurological aberrations and pathophysiology of schizophrenia. The mechanistic aspects of the technique are discussed in brief. Future work should focus on establishing the clinical efficacy of this novel technique and on evaluating this modality as an adjunct to cognitive enhancement protocols. Understanding the mechanism of action of tDCS as well as the determinants and neurobiological correlates of clinical response to tDCS remains an important goal, which will help us expand the clinical applications of tDCS for the treatment of patients with schizophrenia.
Hallucinations
;
Humans
;
Neurobehavioral Manifestations
;
Neuronal Plasticity
;
Schizophrenia*